Burgy, O.* ; Mayr, C.H.* ; Schenesse, D.* ; Fousekis Papakonstantinou, E.* ; Ballester, B. ; Sengupta, A. ; She, Y.* ; Hu, Q.* ; Melo-Narváez, M.C ; Jain, E. ; Pestoni, J. ; Mozurak, M.* ; Estrada-Bernal, A.* ; Onwuka, U.* ; Coughlan, C.* ; Parimon, T.* ; Chen, P.* ; Heimerl, T.* ; Bange, G.* ; Schmeck, B.T.* ; Lindner, M. ; Hilgendorff, A. ; Ruppert, C.* ; Guenther, A.* ; Mann, M.* ; Yildirim, A.Ö. ; Eickelberg, O.* ; Jung, A.L.* ; Schiller, H. ; Lehmann, M. ; Burgstaller, G. ; Königshoff, M.*
Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis.
JCI insight 9:e168889 (2024)
Idiopathic pulmonary fibrosis (IPF) is a lethal chronic lung disease characterized by aberrant intercellular communication, extracellular matrix deposition, and destruction of functional lung tissue. While extracellular vesicles (EVs) accumulate in the IPF lung, their cargo and biological effects remain unclear. We interrogated the proteome of EV and non-EV fractions during pulmonary fibrosis and characterized their contribution to fibrosis. EVs accumulated 14 days after bleomycin challenge, correlating with decreased lung function and initiated fibrogenesis in healthy precision-cut lung slices. Label-free proteomics of bronchoalveolar lavage fluid EVs (BALF-EVs) collected from mice challenged with bleomycin or control identified 107 proteins enriched in fibrotic vesicles. Multiomic analysis revealed fibroblasts as a major cellular source of BALF-EV cargo, which was enriched in secreted frizzled related protein 1 (SFRP1). Sfrp1 deficiency inhibited the activity of fibroblast-derived EVs to potentiate lung fibrosis in vivo. SFRP1 led to increased transitional cell markers, such as keratin 8, and WNT/β-catenin signaling in primary alveolar type 2 cells. SFRP1 was expressed within the IPF lung and localized at the surface of EVs from patient-derived fibroblasts and BALF. Our work reveals altered EV protein cargo in fibrotic EVs promoting fibrogenesis and identifies fibroblast-derived vesicular SFRP1 as a fibrotic mediator and potential therapeutic target for IPF.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Cell Biology ; Fibrosis ; Molecular Biology ; Pulmonology; Exosomes; Pathogenesis; Progenitors; Mechanisms; Responses; Release
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
2379-3708
e-ISSN
2379-3708
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 9,
Issue: 18,
Pages: ,
Article Number: e168889
Supplement: ,
Series
Publisher
Clarivate
Publishing Place
Ann Arbor, Michigan
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30202 - Environmental Health
80000 - German Center for Lung Research
Research field(s)
Lung Research
PSP Element(s)
G-501600-014
G-501600-005
G-505000-001
G-501600-001
G-501800-820
G-501600-003
G-552100-001
G-505000-007
G-501693-001
G-501800-810
Grants
Technology Enhancing Cognition and Health Geriatric Research Education and Clinical Center at the VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA
European Molecular Biology Organization (ERS/EMBO Joint Research Fellowship)
ERS
European Union
French National Research Agency (ANR)
NIH
DZL
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Von Behring Roentgen Foundation
Helmholtz Association
European Respiratory Society
Copyright
Erfassungsdatum
2024-10-29